Literature DB >> 19193894

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein.

Jun Liu1, Jian-Peng Zhang, Min Shi, Thomas Quinn, Joshua Bradner, Richard Beyer, Shengdi Chen, Jing Zhang.   

Abstract

Growing evidence suggests that extracellular alpha-synuclein (eSNCA) may play an important role in the pathogenesis of Parkinson's disease (PD) and related synucleinopathies by producing neurotoxicity directly or via activation of glia. However, the mechanisms involved in the trafficking of eSNCA in neurons and/or glia remain unclear. Here, we demonstrated that eSNCA could be resecreted out of neurons via a process modulated by a recycling endosome regulator rab11a in addition to being degraded by an endosome-lysosome system. A quantitative proteomic analysis also revealed numerous proteins through which rab11a might execute its function. One of the candidate proteins, heat shock protein 90 (HSP90), was validated to be interacting with rab11a. Furthermore, geldanamycin, an HSP90 inhibitor, not only prevented resecretion of eSNCA but also attenuated neurotoxicity induced by eSNCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193894      PMCID: PMC3241981          DOI: 10.1523/JNEUROSCI.6202-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein.

Authors:  J Y Sung; J Kim; S R Paik; J H Park; Y S Ahn; K C Chung
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

2.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

3.  Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments.

Authors:  O M El-Agnaf; R Jakes; M D Curran; D Middleton; R Ingenito; E Bianchi; A Pessi; D Neill; A Wallace
Journal:  FEBS Lett       Date:  1998-11-27       Impact factor: 4.124

4.  Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture.

Authors:  P Sangchot; S Sharma; B Chetsawang; J Porter; P Govitrapong; M Ebadi
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

Review 5.  Heat-shock protein 90, a chaperone for folding and regulation.

Authors:  D Picard
Journal:  Cell Mol Life Sci       Date:  2002-10       Impact factor: 9.261

6.  Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects.

Authors:  R Borghi; R Marchese; A Negro; L Marinelli; G Forloni; D Zaccheo; G Abbruzzese; M Tabaton
Journal:  Neurosci Lett       Date:  2000-06-16       Impact factor: 3.046

7.  Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

Authors:  He-Jin Lee; Smita Patel; Seung-Jae Lee
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

8.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

9.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Analysis of alpha-synuclein-associated proteins by quantitative proteomics.

Authors:  Yong Zhou; Guangyu Gu; David R Goodlett; Terry Zhang; Catherine Pan; Thomas J Montine; Kathleen S Montine; Ruedi H Aebersold; Jing Zhang
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

View more
  64 in total

1.  Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein.

Authors:  Jun Liu; Min Shi; Zhen Hong; JianPeng Zhang; Joshua Bradner; Thomas Quinn; Richard P Beyer; Patrick L Mcgeer; ShengDi Chen; Jing Zhang
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

Review 2.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

4.  Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity.

Authors:  Karin M Danzer; Wolfgang P Ruf; Preeti Putcha; Daniel Joyner; Tadafumi Hashimoto; Charles Glabe; Bradley T Hyman; Pamela J McLean
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

Review 5.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 6.  Targeting heat shock proteins to modulate α-synuclein toxicity.

Authors:  Daryl Rhys Jones; Simon Moussaud; Pamela McLean
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

Review 7.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

Review 8.  α-Synuclein oligomers and clinical implications for Parkinson disease.

Authors:  Lorraine V Kalia; Suneil K Kalia; Pamela J McLean; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 9.  Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

Authors:  Sibylle E Eisbach; Tiago F Outeiro
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

10.  Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

Authors:  Francisco Pan-Montojo; Oleg Anichtchik; Yanina Dening; Lilla Knels; Stefan Pursche; Roland Jung; Sandra Jackson; Gabriele Gille; Maria Grazia Spillantini; Heinz Reichmann; Richard H W Funk
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.